Inhibition of thiazide photohemolysis in vitro by antioxidants and a nitrogen atmosphere

Photodermatology Photoimmunology and Photomedicine

Volumn 12, Issue 5, 1996, Pages 211-215

  Selvaag, E ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Antioxidants; Diuretics; Phototoxicity; Thiazide photohemolysis

Indexed keywords

ACETAZOLAMIDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BEMETIZIDE; BENDROFLUMETHIAZIDE; BENZTHIAZIDE; BENZYLHYDROCHLOROTHIAZIDE; BUMETANIDE; BUTIZIDE; CHLORAZANIL; CHLOROTHIAZIDE; CHLORTALIDONE; CLOPAMIDE; CYCLOPENTHIAZIDE; CYCLOTHIAZIDE; DIAZOXIDE; DIURETIC AGENT; ETOZOLIN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROFLUMETHIAZIDE; INDAPAMIDE; MEFRUSIDE; METOLAZONE; PIRETANIDE; POLYTHIAZIDE; SUPEROXIDE DISMUTASE; THIAZIDE DIURETIC AGENT; TRICHLORMETHIAZIDE; UNCLASSIFIED DRUG; XIPAMIDE;

ARTICLE; ATMOSPHERE; HEMOLYSIS; HUMAN; IN VITRO STUDY; PHOTOLYSIS; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 0030433935     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1996.tb00202.x     Document Type: Article

References (19)

1. Norins AL. Chlorothiazide drug eruption involving photosensitization. Arch Dermatol 1959: 79: 592.
2. Harber LC, Lashinsky AM, Baer RL. Skin manifestations of photosensitivity due to chlorothiazide and hydrochlorothiazide. J Invest Dermatol 1959: 33: 83-84.
3. Harber LC, Lashinsky AM, Baer RL. Photosensitivity due to chlorothiazide and hydrochlorothiazide. New Engl J Med 1959: 261: 1378-1381.
4. Torinuki W. Photosensitivity due to hydrochlorothiazide. J Dermatol (Japan) 1980: 7: 293-296.
5. Düsing R. Diuretika. Stuttgart: Wissenschaftliche Verlags-gesellschaft, 1986.
6. Robinson HN, Morison WL, Hood AF. Thiazide diuretic therapy and chronic photosensitivity. Arch Dermartol 1985: 121: 522-524.
7. Addo HA, Ferguson J, Frain-Bell W. Thiazide-induced photosensitivity: a study of 33 subjects. Br J Dermatol 1987: 116: 749-760
8. Selvaag E. In vitro-Untersuchungen zur Phototoxizität von Sulfonamid-derivierten oralen Antidiabetika und Diuretika. Oslo: Selvaag Medical Publisher, 1996.
9. Selvaag E, Anholt H, Moan J, Thune P. Phototdegradation products of sulphonamide-derived oral antidiabetics and diuretics are not phototoxic in vitro. Photodermatol Photoimmunol Photomed 1996: in press.
10. Matsuo I, Fujita H, Hayakawa K, Ohkido M. Lipid peroxidative potency of photosensitized thiazide diuretics. J Invest Dermatol 1986: 87: 637-641.
11. Johnson BE, Walker EM, Hetherington AM. In vitro models for cutaneous phototoxicity. In: Marks R, Plewig G, eds. Skin models Berlin, Heidelberg, New York: Springer Verlag, 1986: 264-281.
12. Daniels F. A simple microbiological method for demonstrating phototoxic compounds. J Invest Dermatol 1965: 44: 259-263.
13. Ison AE, Davies CM. Phototoxicity of quinoline methanols and other drugs in mice and yeast. J Invest Dermatol 1966: 52: 193-198.
14. Selvaag E, Anholt H, Moan J, Thune P. Phototoxicity due to sulphonamide derived oral antidiabetics and diuretics: investigations in a cell culture model. Photodermatol Photoimmunol Photomed 1996: 12: 1-6.
15. Horio T. Evaluation of drug phototoxicity by photosensitization of Trichophyton mentagrophytes. Br J Dermatol 1981: 105: 365-370.
16. Morison WL, McAuliffe DJ, Parrish JA, Bloch KJ. In vitro assay for phototoxic chemicals. J Invest Dermatol 1982: 78: 460-463.
17. Freeman RG, Murtishaw W, Knox JM. Tissue culture techniques in the study of cell photobiology and phototoxicity. J Invest Dermatol 1970: 54: 164-169.
18. Rooney ML. Ascorbic acid as a photooxidation inhibitor. Photochem Photobiol 1983: 38: 619-629.
19. Bodannes RS, Chan C. Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett 1979: 105: 195-196.